CEO
Enterra Medical, Inc.
St. Louis Park, Minnesota, United States
Peter Sommerness is the CEO of Enterra Medical a commercial stage company founded in 2022 by spinning Enterra Therapy (Gastric Electrical Stimulation) out of Medtronic. Prior to joining Enterra Medical, Peter led Respicardia as President and CEO for four years. Respicardia, founded in 2006 and acquired by ZOLL Medical in 2021, is a leader in neurostimulation technologies that address the unmet needs of people with Central Sleep Apnea (CSA). Prior to leading Respicardia, Peter was a Partner in the healthcare practice of McKinsey & Company. Peter has over 20 years of experience in the active medical device space, including over 12 years of operating experience at Guidant Corporation and Boston Scientific – across Cardiac Electrophysiology (EP) and Cardiac Rhythm Management (CRM). Peter held leadership roles in field sales, market development, upstream marketing and portfolio, including leading the expansion of Boston Scientific’s Cardiac Electrophysiology business as VP and General Manager. Peter holds B.A., B.E. and M.E. degrees in Engineering from Dartmouth College and an M.B.A. with high honors from the University of Chicago.
Bioelectronic medicine:
neuromodulation for Internal Organs
Thursday, January 22, 2026
1:30 PM - 2:15 PM PST